These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 28612199

  • 1. MRI-guided radiotherapy for head and neck cancer: initial clinical experience.
    Chen AM, Hsu S, Lamb J, Yang Y, Agazaryan N, Steinberg ML, Low DA, Cao M.
    Clin Transl Oncol; 2018 Feb; 20(2):160-168. PubMed ID: 28612199
    [Abstract] [Full Text] [Related]

  • 2. Initial clinical experience with helical tomotherapy for head and neck cancer.
    Chen AM, Jennelle RL, Sreeraman R, Yang CC, Liu T, Vijayakumar S, Purdy JA.
    Head Neck; 2009 Dec; 31(12):1571-8. PubMed ID: 19405087
    [Abstract] [Full Text] [Related]

  • 3. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 4. Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer.
    Chen AM, Farwell DG, Luu Q, Cheng S, Donald PJ, Purdy JA.
    Int J Radiat Oncol Biol Phys; 2011 Jul 01; 80(3):669-76. PubMed ID: 20547443
    [Abstract] [Full Text] [Related]

  • 5. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):663-73. PubMed ID: 14967418
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study.
    Berwouts D, Madani I, Duprez F, Olteanu AL, Vercauteren T, Boterberg T, Deron P, Bonte K, Huvenne W, De Neve W, Goethals I.
    Head Neck; 2017 Nov 01; 39(11):2264-2275. PubMed ID: 28833829
    [Abstract] [Full Text] [Related]

  • 7. A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory.
    Schatteman J, Van Gestel D, Berwouts D, De Gersem W, De Kerf G, De Neve W, De Ost B, Olteanu AML, Rottey S, Vercauteren T, Goethals I, Duprez F.
    Strahlenther Onkol; 2018 Aug 01; 194(8):727-736. PubMed ID: 29556677
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 9. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS, Kim H, Houser CJ, Kelley JL, Sukumvanich P, Edwards RP, Comerci JT, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S.
    Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):540-7. PubMed ID: 25680598
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
    Chen AM, Farwell DG, Luu Q, Donald PJ, Perks J, Purdy JA.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):943-9. PubMed ID: 20932680
    [Abstract] [Full Text] [Related]

  • 11. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
    Castelli J, Simon A, Rigaud B, Chajon E, Thariat J, Benezery K, Vauleon E, Jegoux F, Henry O, Lafond C, de Crevoisier R.
    Acta Oncol; 2018 Sep 15; 57(9):1267-1270. PubMed ID: 29706107
    [No Abstract] [Full Text] [Related]

  • 12. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
    Chen AM, Daly ME, Cui J, Mathai M, Benedict S, Purdy JA.
    Head Neck; 2014 Nov 15; 36(11):1541-6. PubMed ID: 23996502
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
    Dyk P, Jiang N, Sun B, DeWees TA, Fowler KJ, Narra V, Garcia-Ramirez JL, Schwarz JK, Grigsby PW.
    Int J Radiat Oncol Biol Phys; 2014 Nov 15; 90(4):794-801. PubMed ID: 25245584
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.
    Schwartz DL, Garden AS, Thomas J, Chen Y, Zhang Y, Lewin J, Chambers MS, Dong L.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):986-93. PubMed ID: 22138459
    [Abstract] [Full Text] [Related]

  • 17. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
    Chen AM, Daly ME, Farwell DG, Vazquez E, Courquin J, Lau DH, Purdy JA.
    JAMA Otolaryngol Head Neck Surg; 2014 Feb 01; 140(2):129-33. PubMed ID: 24337483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.